Oxford BioDynamics (LON:OBD) Stock Price Down 3.2% – Here’s Why

by · The Cerbat Gem

Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s share price dropped 3.2% during trading on Monday . The company traded as low as GBX 1.20 ($0.02) and last traded at GBX 1.20 ($0.02). Approximately 354,030 shares traded hands during trading, a decline of 81% from the average daily volume of 1,843,727 shares. The stock had previously closed at GBX 1.24 ($0.02).

Oxford BioDynamics Stock Down 0.8 %

The company has a market capitalization of £3.77 million, a PE ratio of -19.25 and a beta of 0.42. The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80. The business’s 50 day simple moving average is GBX 2.34 and its 200 day simple moving average is GBX 5.57.

Insider Buying and Selling at Oxford BioDynamics

In other Oxford BioDynamics news, insider David Holbrook bought 49,653 shares of the business’s stock in a transaction that occurred on Monday, October 28th. The shares were purchased at an average cost of GBX 1 ($0.01) per share, with a total value of £496.53 ($628.28). 16.78% of the stock is owned by corporate insiders.

Oxford BioDynamics Company Profile

(Get Free Report)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.

See Also